N328026 N3 Ruling Active

The tariff classification of Arformoterol Tartrate Inhalation Solution in dosage form, from Germany

Issued October 3, 2022 by U.S. Customs and Border Protection.

Tariff classification

HTS codes: 3004.90.9285

Headings: 3004

Product description

Arformoterol Tartrate, imported in 15 mcg/2 mL inhalation solution, is a selective beta2-adrenergic bronchodilator. It is indicated for long term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema.

CBP rationale

The applicable subheading for the Arformoterol Tartrate Inhalation Solution in dosage form will be 3004.90.9285, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the eyes, ears, or respiratory system: Other: Other.

Full text

N328026 October 3, 2022 CLA-2-30:OT:RR:NC:N3:138 CATEGORY: Classification TARIFF NO.: 3004.90.9285 Sateesh Reddy Ambati Slayback Pharma LLC 301 Carnegie Center Princeton, NJ 08540 RE: The tariff classification of Arformoterol Tartrate Inhalation Solution in dosage form, from Germany Dear Mr. Ambati: In your letter dated September 7, 2022, you requested a tariff classification ruling. Arformoterol Tartrate, imported in 15 mcg/2 mL inhalation solution, is a selective beta2-adrenergic bronchodilator. It is indicated for long term maintenance treatment of bronchoconstriction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. The applicable subheading for the Arformoterol Tartrate Inhalation Solution in dosage form will be 3004.90.9285, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Medicaments primarily affecting the eyes, ears, or respiratory system: Other: Other.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on the World Wide Web at https://hts.usitc.gov/current. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Judy Lee at [email protected]. Sincerely, Steven A. Mack Director National Commodity Specialist Division

View original on CBP CROSS →

More rulings on the same tariff codes

Searching CBP rulings the smart way

TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.

Book a demo →